As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Subscribe to Curetis Newsletter
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
Curetis’ Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test
BOA 2018, British Orthopaedic Association - Birmingham, United Kingdom - September 25 to 28, 2018
ID Week - Infectious Disease 2018 - San Fransisco, USA - October 3 to 7, 2018